Trial intelligence / Profile preview

Transdermal lidocaine in painful peripheral diabetic neuropathy by sensory phenotype

2009-013706-13Phase 4Completed

Sponsor
Klinik Ottakring
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of lidocaine in diabetic polyneuropathy (DPN), sponsored by Klinik Ottakring. Primary endpoints: Global patient treatment satisfaction and Good treatment responder rate. Started Nov 2010; status: completed.

02

Drugs

lidocaine
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on 2009-013706-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013706-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call